Ingenol Topical application
Name: Ingenol Topical application
- Ingenol Topical application used to treat
- Ingenol Topical application is used to treat
- Ingenol Topical application side effects
- Ingenol Topical application effects of
- Ingenol Topical application adverse effects
- Ingenol Topical application drug
Uses For ingenol
Ingenol topical is used to treat a skin condition called actinic keratosis.
ingenol is available only with your doctor's prescription.
Commonly reported side effects of ingenol topical include: dermal ulcer, localized vesiculation, skin erosion, swelling of skin, and erythema. See below for a comprehensive list of adverse effects.
For the Consumer
Applies to ingenol topical: topical application gel/jelly
Along with its needed effects, ingenol topical may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking ingenol topical:More common
- Blistering, peeling, or loosening of the skin
- pain and itching at the application site
- redness of the skin (severe)
- skin ulcers
- swelling of the skin
- Burning, dry, or itching eyes
- discharge or excessive tearing
- eye pain
- infection at the application site
- redness, pain, or swelling of the eye, eyelid, or inner lining of the eyelid
- swelling around the eyes
Some side effects of ingenol topical may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:More common
- Flaking or scaling of the skin
- redness of the skin (mild)
Data not available
Ingenol topical Breastfeeding Warnings
The manufacturer makes no recommendation regarding use during lactation. Excreted into human milk: Data not available Excreted into animal milk: Data not available Comments: -Physical contact between the newborn/infant and the treated area should be avoided for a period of 6 hours after application of this drug.